| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to compounds of formula 1, where G represents a group (1) , where R 9 represents an aryl, optionally substituted with C 1 -C 3 alkoxy or halogen; or (2) a substituded or non-substituted azole or pyrrole ring, condensed with a substituted or non-substituted aryl, heteroaryl, C 5 -C 6 cycloalkyl or heterocyclyl, or to its pharmaceutically acceptable salts, methods of its obtaining and application in the treatment of proliferative disorders, such as cancer. n EFFECT: obtaining the compounds for the treatment of proliferative disorders, such as cancer. n 32 cl, 1 tbl, 91 ex |